so long 20/21 FY year... onwards and upwards, page-88

what an indictment on management:

- they are sitting on groundbreaking tech
- have a great product which integrates with a number of key hospital platforms
- have had independent research confirm the efficacy of APAS
- they have announced multiple
times to market that FDA MSRA approval and US distributor deal expected within next 3 weeks of trading (not a long time to wait for a return)
- these announcements are likely to see at least a 50% increase in SP in the immediate term with a serious relate warranted (all IMO )

and yet the SP is going down. clearly the whole market doesn't trust what BB is saying. it is an extraordinary situation.